PARP15 Antibody

What is PARP15 and why is it relevant to study with antibodies?

PARP15 (also known as ARTD7) is a mono-ADP-ribosyltransferase that belongs to the subfamily of macrodomain-containing PARP enzymes along with PARP9 and PARP14. Originally identified as B-aggressive lymphoma (BAL) proteins, PARP15 contains two macrodomains and an ADP-ribosyltransferase (ART) domain . Evolutionary analysis strongly ties PARP15 to virus defense, and recent studies indicate it can ADP-ribosylate RNA and localize to stress granules, suggesting functions in translation regulation .

Antibodies against PARP15 are critical research tools that enable:

• Detection of endogenous PARP15 protein expression

• Visualization of subcellular localization

• Monitoring of post-translational modifications

• Immunoprecipitation for protein-protein interaction studies

• Validation of genetic manipulation experiments

What applications are PARP15 antibodies validated for?

Most commercially available PARP15 antibodies are validated for the following applications:

When selecting a PARP15 antibody, researchers should verify the specific validation data for their application of interest, as performance can vary significantly between applications .

How should PARP15 antibody samples be prepared and stored?

Proper storage and handling of PARP15 antibodies is crucial for maintaining their performance:

• Short-term storage (up to 2 weeks): Refrigerate at 2-8°C

• Long-term storage: Store at -20°C in small aliquots to prevent freeze-thaw cycles

• Avoid repeated freeze-thaw cycles that can denature the antibody

• Consider adding glycerol (final concentration 30-50%) for cryoprotection

• Some antibodies are provided without preservatives, which may affect stability

When preparing samples for PARP15 detection, optimal lysis conditions are important to maximize retention of ADP-ribosylation signals, particularly because these modifications can be labile .

How do different detection reagents affect PARP15 antibody specificity and sensitivity?

Different detection reagents show varying affinities for ADP-ribosylation modifications introduced by PARP15:

Research indicates that murine PARP14 macrodomain-based detection reagents have higher affinity for ADP-ribose than human macrodomains and appear efficient for immunoprecipitation of ADP-ribosylated nucleic acids .

How can I optimize Western blotting protocols specifically for PARP15 detection?

Western blotting optimization for PARP15 detection requires attention to several factors:

• Sample preparation: Use optimized lysis buffers that preserve ADP-ribosylation modifications

  • Include PARP inhibitors to prevent post-lysis modifications

  • Remove nuclei and mitochondria which contain high amounts of PARP1, TARG1, and MACROD1 that could confound the assay

• Protein separation:

  • Use 7.5-10% acrylamide gels for optimal separation of PARP15 (~75-80 kDa)

  • Consider gradient gels for better resolution of modified forms

• Transfer conditions:

  • Semi-dry transfer at lower voltage for extended time improves transfer of larger proteins

  • Wet transfer may provide better results for detecting modified PARP15

• Blocking and antibody incubation:

  • Optimize blocking agent (BSA vs. milk) as milk contains hydrolases that can remove ADP-ribosylation

  • Primary antibody dilution typically ranges from 1:500 to 1:2000 depending on the specific antibody

  • Extended primary antibody incubation (overnight at 4°C) may improve signal

• Storage of ADP-ribosylated samples:

  • Extended storage, even at -20°C, may lead to degradation of ADP-ribosylation modifications

  • Prepare fresh samples when possible for critical experiments

What are the differences between commercially available PARP15 antibodies?

Several PARP15 antibodies are commercially available with different characteristics:

When selecting between these options, consider:

• The specific region of PARP15 you need to detect (full-length vs. specific domains)

• The host species (to avoid cross-reactivity with secondary detection systems)

• Validation data for your specific application

• The need for detecting specific PARP15 isoforms (human has two isoforms with structural differences)

How can PARP15 antibodies be used to study its dimerization and activity regulation?

Recent research has revealed that PARP15 ART domain forms a dimer in solution, and this dimerization is required for MARylation activity . PARP15 antibodies can be instrumental in studying this regulatory mechanism:

• Co-immunoprecipitation approaches:

  • Use PARP15 antibodies to immunoprecipitate the protein complex

  • Western blot analysis can reveal dimerization partners

  • Cross-linking prior to immunoprecipitation can stabilize transient interactions

• Proximity ligation assays (PLA):

  • Combine PARP15 antibodies with antibodies against potential interaction partners

  • PLA signals indicate proximity (<40 nm) suggesting protein-protein interactions

  • Particularly useful for visualizing dimerization in cellular contexts

• FRET/BRET assays with antibody validation:

  • Generate fluorescently tagged PARP15 constructs

  • Use antibodies to validate expression and functionality

  • FRET/BRET measurements can provide real-time dimerization dynamics

• Structure-function analysis:

  • Generate mutants targeting the dimer interface observed in X-ray crystallography

  • Use antibodies to confirm expression levels of mutants

  • Correlate dimerization status with catalytic activity using activity assays

The crystal structure-derived dimer interface appears identical to the interface observed in solution, suggesting this is the physiologically relevant dimerization mechanism for PARP15 activity regulation .

What methodologies exist for studying PARP15-mediated RNA modification using antibodies?

PARP15 has recently been shown to ADP-ribosylate 5'-phosphorylated RNA ends . Studying this novel function requires specialized approaches:

• Immunoprecipitation of ribonucleoprotein complexes:

  • Use PARP15 antibodies to immunoprecipitate PARP15-RNA complexes

  • Extract and analyze bound RNA using RT-PCR or RNA-seq

  • Murine PARP14 macrodomain-based detection reagents show efficient immunoprecipitation of ADP-ribosylated nucleic acids

• Sequential immunoprecipitation approach:

  • First immunoprecipitate with PARP15 antibodies

  • Then immunoprecipitate with anti-ADP-ribose antibodies

  • This enriches for RNA specifically modified by PARP15

• In vitro RNA modification assay with antibody detection:

  • Incubate purified PARP15 with RNA substrates and NAD+

  • Use anti-ADP-ribose antibodies to detect modification

  • Chemiluminescent detection systems can provide quantitative results

• Stress granule co-localization studies:

  • Use PARP15 antibodies in combination with stress granule markers

  • Analyze co-localization during various stress conditions

  • PARP15 localizes to stress granules which form upon exposure to stressors including viral infection

When selecting detection reagents, note that different antibodies show varying specificities for ADP-ribosylation modifications on different substrates, including RNA .

How can researchers investigate PARP15's evolutionary relationship with antiviral defense using antibodies?

PARP15's evolutionary history suggests significant roles in antiviral defense, with evidence of positive selection and gene duplication/loss patterns reflecting host-pathogen interactions . Antibody-based approaches to investigate this include:

• Comparative immunology approaches:

  • Test cross-reactivity of PARP15 antibodies across species

  • Analyze expression patterns in different species following viral challenges

  • PARP15 originated by partial duplication of PARP14 early in mammalian evolution but was subsequently lost in some lineages

• Stress granule formation during viral infection:

  • Monitor PARP15 localization to stress granules during viral infection using immunofluorescence

  • Analyze co-localization with viral components

  • Compare with other macrodomain-containing PARPs (PARP9, PARP14) which have established antiviral roles

• ADP-ribosylome analysis during infection:

  • Use PARP15 antibodies to immunoprecipitate and identify substrates

  • Compare substrate profiles between normal and infected states

  • Integrate with proteomics approaches to identify infection-specific modifications

• Viral antagonism of PARP15:

  • Investigate whether viral proteins interact with PARP15

  • Use antibodies to monitor PARP15 degradation or relocalization during infection

  • Compare with known viral antagonism of other PARP family members

The evolutionary evidence of positive selection in PARP9, PARP14, and PARP15—the only three human genes containing both PARP domains and macrodomains—strongly suggests their importance in host-pathogen interactions .

What methodological approaches can detect different amino acid ADP-ribosylation by PARP15?

Different amino acids have been identified as ADPr acceptors, including glutamates, serines, tyrosines, histidines, and cysteines . Investigating PARP15's amino acid modification specificity requires specialized approaches:

• Mass spectrometry with antibody enrichment:

  • Use PARP15 antibodies to immunoprecipitate modified proteins

  • Employ specialized sample preparation to preserve modifications

  • Different fragmentation methods can help identify specific modification sites

• Amino acid-specific ADPr antibodies:

  • Some antibodies are specific for ADP-ribosylation on particular amino acids

  • Use in combination with PARP15 antibodies for co-localization studies

  • The Matic laboratory has generated antibodies against MARylated serines and a general ADPr antibody

• Hydrolase treatment approach:

  • Different hydrolases cleave ADPr from specific amino acids

  • Compare PARP15 antibody signals before and after treatment with:

    • MACROD1 (removes ADPr from acidic residues)

    • ARH3 (removes ADPr from serine residues)

    • ARH1 (removes ADPr from arginine)

• Site-directed mutagenesis validation:

  • Mutate potential target amino acids in substrate proteins

  • Use PARP15 antibodies to assess modification levels

  • Compare with activity assays using purified components

The analytical approach should consider that PARP15 has higher affinity for NAD+ and modifies more sites on itself in vitro compared to its close relative PARP14 .

What are the optimized sample preparation procedures for maintaining PARP15 ADP-ribosylation signals?

Sample preparation is critical for preserving ADP-ribosylation modifications, which can be labile. Optimized procedures include:

• Cell lysis optimization:

  • Use buffers containing PARP inhibitors (e.g., PJ34, olaparib)

  • Include ADPr hydrolase inhibitors (e.g., ADP-HPD)

  • Remove nuclei and mitochondria as they contain high amounts of PARP1, TARG1, and MACROD1 that could confound assays

• Protein extraction for maximum ADPr retention:

  • Direct lysis in SDS-PAGE loading buffer preserves modifications

  • For non-denaturing approaches, use mild detergents with inhibitor cocktails

  • Keep samples cold throughout processing

• Fixation methods for immunofluorescence:

  • Different fixation methods affect the recognition of ADP-ribosylation by antibodies

  • Compare methanol vs. paraformaldehyde fixation

  • Include appropriate controls with ADP-ribosylation inhibitors

• Storage considerations:

  • ADP-ribosylation signals can degrade even when stored at -20°C

  • For critical experiments, prepare fresh samples

  • When analyzing PARylation, consider that long storage can lead to degradation

• Validation controls:

  • Include PARP inhibitor-treated samples as negative controls

  • Consider PARP15 knockdown/knockout controls

  • Use hydrolase treatments as specificity controls

Optimized sample preparation procedures enable detection of low ADP-ribosylation levels and are essential for studying PARP15's biological functions in various contexts .